
trilipix
Pharmaranks rates Trilipix 3.6/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Trilipix (Choline Fenofibrate) is a peroxisome proliferator receptor alpha agonist.
Choline Fenofibrate · by Abbvie
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Choline Fenofibrate
- Form
- Capsule, delayed release
- Strength
- Choline Fenofibrate EQ 135MG Fenofibric Acid **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons** · Choline Fenofibrate EQ 45MG Fenofibric Acid **Federal Register Determination That Product was not Discontinued or Withdrawn for Safety or Effectiveness reasons**
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- Manufacturer
- Abbvie
- Half-life
- about 20 hours — but that is the half-life of fenofibric acid, the active form, not of fenofibrate itself (how long it stays in your system)
- FDA application
- NDA022224
- Availability
- Discontinued (per FDA)
How long does Choline Fenofibrate stay in your body?
The elimination half-life of choline fenofibrate is about 20 hours — but that is the half-life of fenofibric acid, the active form, not of fenofibrate itself — the time it takes the body to clear about half of it. As a rule of thumb, a medicine is mostly gone after roughly 4 to 5 half-lives, though this varies from person to person with age and kidney or liver function. Fenofibrate is a prodrug. The label states it "is a pro-drug of the active chemical moiety fenofibric acid" and that after an oral dose it is "rapidly hydrolyzed by esterases to the active metabolite, fenofibric acid; no unchanged fenofibrate is detected in plasma." So there is no parent half-life to report — the label gives only one figure: "Fenofibric acid is eliminated with a half-life of 20 hours, allowing once daily dosing." That 20 hours is the elimination (terminal) half-life of the active moiety; the label reports no separate distribution phase. Kidney function matters: the label says patients with mild to moderate renal impairment (eGFR 30–59 mL/min/1.73m2) had similar exposure but "an increase in the half-life for fenofibric acid" compared with healthy subjects (it does not say by how much), and severe impairment (eGFR under 30) showed a 2.7-fold increase in exposure with accumulation on chronic dosing — the label says to avoid fenofibrate in severe renal impairment and to reduce the dose in mild-to-moderate. Older adults: in volunteers aged 77–87 the oral clearance of fenofibric acid was 1.2 L/h versus 1.1 L/h in young adults, i.e. essentially unchanged, so no age-related prolongation is described in those with normal renal function. Liver impairment: the label states no pharmacokinetic studies have been conducted in hepatic impairment, so the half-life there is unknown.
This is general information, not medical advice. It doesn’t tell you when a drug test would read negative (tests detect substances for different, often longer, windows) or when it’s safe to take another dose — ask your pharmacist or prescriber. Source: FENOFIBRATE tablet — DailyMed label, §12.3 Pharmacokinetics.
Drug class
Dosage forms
Capsule, delayed release
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- How is Trilipix rated?
- pharmaranks gives Trilipix a composite score of 3.6 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Trilipix?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Trilipix. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Trilipix?
- Trilipix is marketed by Abbvie. You can see Abbvie's full profile, rating, and other products on pharmaranks.
- Is Trilipix a brand-name or generic drug?
- Trilipix is a brand-name product with the active ingredient Choline Fenofibrate.
- Is Trilipix available over the counter?
- No. Trilipix is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Trilipix come in?
- Trilipix is currently marketed as capsule, delayed release, per the FDA's National Drug Code Directory.
- What class of drug is Trilipix?
- Trilipix is classified as peroxisome proliferator receptor alpha agonist, per the FDA's Established Pharmacologic Class.
- Is Trilipix FDA-registered?
- Trilipix is on record with the U.S. FDA under application number NDA022224. You can verify this on its official FDA label.
- Has Trilipix been recalled by the FDA?
- Trilipix has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Trilipix safe?
- There's no single safe-or-not verdict. pharmaranks gives Trilipix a recall-safety score of 72/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Trilipix head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
trilipix
72/100